Clinical Trials

Spinocerebellar ataxia

Displaying 2 studies

A Study to Evaluate BHV-4157 in Adult Subjects with Spinocerebellar Ataxia Jacksonville, FL

The purpose of this study is to compare the effectiveness of BHV-4157 (200mg once daily) versus placebo after 48 weeks of treatment in subjects with spinocerebellar ataxia (SCA).
A Study on Mayo Clinic Patients with Friedreich Ataxia Rochester, MN

The purpose of this study is to create a clinical registry of patients with FRDA seen at Mayo Clinic.